EUVIMEDEUVIMED entdecken
Crossref

Utility of next-generation sequencing for the genetic study of MODY diabetes

Marta Expósito García iD, María Desamparados Sarabia Meseguer, Antonio Miguel Hernández Martínez, Aurora Aragón Alonso, Manuela Fernández López, Gabriel Angel Macanás Botía, María Fátima Illán Gómez, Georgios Kyriakos, Antonio Hernández López, Ana María Cerón Moreno, Cristina Guirao Blázquez, Juan José Sánchez Cuenca und 4 weitere

Journal of Endocrinology · 2026

DOI: 10.1530/joe-25-0344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology, 2026. Verfasst von Marta Expósito García und 15 weiteren Autor:innen. Beteiligte Einrichtung: Genomics Laboratory, Clinical Analysis Department, Virgen de la Arrixaca University Clinical Hospital, Carretera Madrid-Cartagena, El Palmar, Murcia,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, High-Throughput Nucleotide Sequencing. Die Arbeit nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Next-generation sequencing (NGS) is increasingly used for diagnosing monogenic forms of diabetes, including maturity-onset diabetes of the young (MODY). We aimed to evaluate the utility of NGS in patients with clinical suspicion of MODY, analyzing genotype–phenotype correlations. A total of 150 unrelated patients from the Region of Murcia (Spain) with suspected MODY were included. Whole-exome sequencing was performed and validated with Sanger and multiplex ligation-dependent probe amplification (MLPA). Variants were classified according to the American College of Medical Genetics and Genomics (ACMG) criteria. Relevant clinical data were collected per the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) criteria and analyzed using SPSS v.27.0.2.0. The diagnostic yield was 16.67% (25/150). Pathogenic or likely pathogenic variants were mainly identified in GCK (38.89%) and HNF1A (33.33%). Significant differences were found between patients with and without genetic diagnosis in family history, age of onset, and body mass index ( P < 0.05). Variants of uncertain significance (VUS) were identified in 22 families (14.66%). One VUS was reclassified as likely pathogenic, and three were prioritized for further evaluation. NGS is a valuable tool for the genetic diagnosis of MODY. Integration of clinical data and systematic re-evaluation and prioritization of VUS can enhance diagnostic accuracy and inform clinical decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2High-Throughput Nucleotide SequencingHumansFemaleMaleAdultHepatocyte Nuclear Factor 1-alphaAdolescentGenetic Association StudiesYoung AdultMiddle AgedChildGerminal Center KinasesMutation

Stichwörter der Autor:innen

MODYVUSmonogenic diabetesnext-generation sequencingvariants of uncertain significance

Substanzen

Hepatocyte Nuclear Factor 1-alphaHNF1A protein, humanGerminal Center KinasesMAP4K2 protein, human

Autor:innen und Institutionen

  • Genomics Laboratory, Clinical Analysis Department, Virgen de la Arrixaca University Clinical Hospital, Carretera Madrid-Cartagena, El Palmar, Murcia, Spain.
  • Department of Biochemistry and Molecular Biology B and Immunology, University of Murcia, Murcia, Spain.
  • Clinical Genetics; Hematology and Clinical-Experimental Oncology; Molecular Therapies and Biomarkers of Solid Tumors, Biomedical Research Institute of Murcia "Pascual Parrilla" (IMIB-Arrixaca), Murcia, Spain.
  • Endocrinology and Nutrition Department, Virgen de la Arrixaca University Clinical Hospital, Carretera Madrid-Cartagena, El Palmar, Murcia, Spain.
  • Endocrinology and Nutrition Department, Morales Meseguer University Clinical Hospital, Marqués de los Vélez, Murcia, Spain.
  • Endocrinology and Nutrition Department, Santa Lucía University Clinical Hospital, Mezquita, Cartagena, Murcia, Spain.

ORCID-Profile: Marta Expósito García

Zitieren

APA

Expósito García, M., Sarabia Meseguer, M. D., Hernández Martínez, A. M., Aragón Alonso, A., Fernández López, M., Macanás Botía, G. A., Illán Gómez, M. F., Kyriakos, G., Hernández López, A., Cerón Moreno, A. M., Guirao Blázquez, C., Sánchez Cuenca, J. J., Pascual Gilabert, P., Antón Martínez, D., Noguera Velasco, J. A., & Ruiz Espejo, F. (2026). Utility of next-generation sequencing for the genetic study of MODY diabetes. Journal of Endocrinology. https://doi.org/10.1530/joe-25-0344

Vancouver

Expósito García M, Sarabia Meseguer MD, Hernández Martínez AM, Aragón Alonso A, Fernández López M, Macanás Botía GA, et al. Utility of next-generation sequencing for the genetic study of MODY diabetes. Journal of Endocrinology. 2026. doi:10.1530/joe-25-0344

BibTeX
@article{ExpsitoGarca2026,
  author = {Expósito García, Marta and Sarabia Meseguer, María Desamparados and Hernández Martínez, Antonio Miguel and Aragón Alonso, Aurora and Fernández López, Manuela and Macanás Botía, Gabriel Angel and Illán Gómez, María Fátima and Kyriakos, Georgios and Hernández López, Antonio and Cerón Moreno, Ana María and Guirao Blázquez, Cristina and Sánchez Cuenca, Juan José and Pascual Gilabert, Patricia and Antón Martínez, David and Noguera Velasco, José Antonio and Ruiz Espejo, Francisco},
  title = {Utility of next-generation sequencing for the genetic study of MODY diabetes},
  journal = {Journal of Endocrinology},
  year = {2026},
  doi = {10.1530/joe-25-0344}
}
Kostenlos starten →